AVITA Medical, Inc. (RCEL) Other Operating Expenses (2018 - 2026)

AVITA Medical (RCEL) has reported Other Operating Expenses for 9 consecutive years, with $5.1 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Other Operating Expenses fell 0.76% year-over-year to $5.1 million; the trailing twelve-month figure through Jun 2026 stood at $19.6 million (down 9.43% YoY), and the FY2025 full-year result was $20.8 million, up 2.35% from the prior year.
• Other Operating Expenses retreated to $5.1 million in Q2 2026 per RCEL's latest filing, from $5.7 million in the prior quarter.
• Across five years, Other Operating Expenses topped out at $6.3 million in Q1 2025 and bottomed at $59000.0 in Q4 2023.
• Historically, Other Operating Expenses has averaged $3.1 million across 5 years, with a median of $4.3 million in 2024.
• The sharpest annual moves came in 2023 and 2024: Other Operating Expenses plunged 94.25% in 2023, then soared 8120.34% in 2024.
• Over 5 years, Other Operating Expenses stood at $1.0 million in 2022, then slumped by 94.25% to $59000.0 in 2023, then jumped by 8120.34% to $4.8 million in 2024, then grew by 17.34% to $5.7 million in 2025, then decreased by 10.77% to $5.1 million in 2026.
• According to Business Quant data, Other Operating Expenses over the past three periods registered $5.1 million, $5.7 million, and $3.7 million for Q2 2026, Q4 2025, and Q3 2025 respectively.